Firm
The firm reported a small uptick in overall revenue and profit per equity partner, while its IP team secured notable life sciences victories
Paul Ainsworth, who secured a settlement for his client in a patent dispute, says the case shows why medical claims by dietary supplement companies can threaten IP rights
Boies Schiller Flexner joins forces with Grünecker to target Skechers in Europe following US lawsuit
Helen Mutimer discusses how the firm’s IP advisory services are filling a gap in the market, and why life sciences work is soaring
Sponsored
Sponsored
-
Sponsored by Bird & BirdWilliam Warne of Bird & Bird describes why some recent judgments have the potential to significantly alter the dynamic in UK FRAND cases -
Sponsored by Liu, Shen & AssociatesYanan Deng and Jinlin Chen of Liu Shen & Associates explain why a good patent portfolio for 5G is so valuable in business
-
Sponsored by Hanol IP & LawMin Son of Hanol IP & Law looks at the changing trend of how courts are determining the similarity of trademarks in South Korea
-
Sponsored by ABE & PartnersTakanori Abe of Abe & Partners looks at a recent judgment which explored how directors are directly liable for the patent infringement of their companies
-
Sponsored by Patrinos & KilimirisMaria Kilimiris of Patrinos & Kilimiris considers how the EUIPO and Greek courts decided on a trademark dispute on the content of pharma goods
-
Sponsored by Adams & AdamsGodfrey Budeli and Jan-Harm Swanepoel of Adams & Adams explain the latest developments in anti-counterfeiting, in the first of a three-part podcast series on IP enforcement of pharma in Africa
